Journal profile · HEMATOLOGY
Turkish Journal of Hematology
ISSN 1300-7777 · eISSN 1308-5263 · Aves · TURKEY · Quarterly · Founded 1995
Turkish Journal of Hematology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.53; fully open access; no APC; review about 1 month (community reports); community-reported acceptance: about 75%; 97 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Turkish Journal of Hematology is published by Aves and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research, together about 25.8% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
The Turkish Journal of Hematology is published quarterly (March, June, September, and December) by the Turkish Society of Hematology. It is an independent, non-profit peer-reviewed international English-language periodical encompassing subjects relevant to hematology. The Editorial Board of The Turkish Journal of Hematology adheres to the principles of the World Association of Medical Editors (WAME), International Council of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), Consolidated Standards of Reporting Trials (CONSORT) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). The aim of The Turkish Journal of Hematology is to publish original hematological research of the highest scientific quality and clinical relevance. Additionally, educational material, reviews on basic developments, editorial short notes, images in hematology, and letters from hematology specialists and clinicians covering their experience and comments on hematology and related medical fields as well as social subjects are published. As of December 2015, The Turkish Journal of Hematology does not accept case reports. Important new findings or data about interesting hematological cases may be submitted as a brief report.
Source: LetPub
Research area (LetPub): HEMATOLOGY
Editor-in-chief Reyhan KüçükkayaPublisher website
Editorial board by country: none in mainland China; most named Türkiye 11 (11 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine9%
- Lymphoma Diagnosis and TreatmentMedicine8.5%
- Chronic Lymphocytic Leukemia ResearchMedicine8.3%
- Hemoglobinopathies and Related DisordersMedicine6.1%
- Chronic Myeloid Leukemia TreatmentsMedicine6.1%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.3%
- Multiple Myeloma Research and TreatmentsMedicine5.3%
- Blood groups and transfusionMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.53LetPub ·
- CiteScore 2026-06
- 2.7LetPub ·
- SJR 2026-06
- 0.51LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 14LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 227OpenAlex ·
- 2-year mean citedness
- 0.79OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 98.84%LetPub ·
Volume
- Articles per year
- 27LetPub ·
Articles by year OpenAlex count · 1,507 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 65 | 65 | 43 |
| 2025 | 97 | 97 | 32 |
| 2024 | 62 | 62 | 102 |
| 2023 | 77 | 77 | 135 |
| 2022 | 51 | 51 | 144 |
| 2021 | 76 | 76 | 308 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- brief reportsBRIEF REPORTS 9. Increased Mast Cell Numbers in Bone Marrow of Patients with Myeloproliferative Neoplasms and PruritusLength not stated
- editorialEDITORIAL 1. 75 Years of Adventure in Turkish Scientific Medical Publishing: From Istanbul Contribution to Clinical Science to Turkish Journal of Hematology (19…Length not stated
- images in hematologyIMAGES IN HEMATOLOGY 11. Hemolytic Anemia in a Newborn: Thinking About Infantile PyknocytosisLength not stated
- letter to the editorLETTER TO THE EDITOR 13. CMV PCR Monitoring for Hematological MalignancyLength not stated
- original articleORIGINAL ARTICLE 2. Liver and Spleen Point Shear-Wave Elastography in Newly Diagnosed BCR: : ABL1-Negative Myeloproliferative NeoplasmsLength not stated
- perspective in hematologyPERSPECTIVE IN HEMATOLOGY 7. Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treat…Length not stated
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright
Copyright notice present Model summary
Copyright © 2026 Turkish Journal of Hematology
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Aves
- Country or region
- TURKEY
- Language
- English, Turkish
- Frequency
- Quarterly
- Founded
- 1995
- ISSN
- 1300-7777
- Electronic ISSN
- 1308-5263
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Turkish Journal of Hematology
What CAS zone is Turkish Journal of Hematology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Turkish Journal of Hematology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Turkish Journal of Hematology?
The latest impact factor listed by LetPub is 1.53; CiteScore 2.7, h-index 31.
How long does peer review take at Turkish Journal of Hematology?
Authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Turkish Journal of Hematology based?
Of the 11 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Türkiye (11). Counted from the institutions listed on the board page; for reference only.
Which databases index Turkish Journal of Hematology?
According to LetPub and DOAJ records, Turkish Journal of Hematology is indexed in SCIE, Scopus and DOAJ.
Is Turkish Journal of Hematology open access, and what is the APC?
Turkish Journal of Hematology is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .